Actavis Pharma, Inc. Recalls

Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed...

CGMP Deviations: use of an unapproved raw material

Clonidine Transdermal System Recall Expanded for CGMP Deviations in 113,943 Cartons (2026)

Teva-affiliated Clonidine Transdermal System recalls 113,943 cartons after CGMP deviations. Unapproved raw material prompts recall. Stop use immediately and contact Teva or a healthcare provider for guidance.

Teva Clonidine Transdermal System Recall Expands Over CGMP Deviations, 124,054 Cartons Affected (202

CGMP Deviations: use of an unapproved raw material

Teva Metoprolol Succinate 50 mg Extended-Release Recall 2026 Following Failed Dissolution Specs (67,

Teva Isotretinoin 40 mg Capsules Recalled for Superpotent and Subpotent Lots (D-0446-2026)

Teva Pharmaceuticals USA, Inc. recalls 8,376 isotretinoin 40 mg capsules distributed to FL, OH, PR and MS after FDA enforcement report flags superpotent and subpotent lots. Patients should stop use and contact their healthcare providers for guidance.

Teva Isotretinoin 30 mg Recall Active for Potency Variations in 10-Count Packs

Teva Pharmaceuticals USA, Inc. recalls 21,984 packages of Isotretinoin Capsules, USP, 30 mg. The lots are distributed to Florida, Ohio, Puerto Rico and Mississippi. The recall is active as of April 15, 2026.

Actavis Recalls Testosterone Gel Due to Leakage Risk

Defective Container - A defect in the side-seal which allows leakage of product.